Antineoplaston researcher Burzynski indicted by federal grand jury on 75 fraud counts.
This article was originally published in The Tan Sheet
Executive Summary
ANTINEOPLASTON PROMOTER BURZYNSKI INDICTED BY HOUSTON FEDERAL GRAND JURY on 75 counts of mail fraud, contempt and FDA violations, Southern Texas U.S. Attorney Gaynelle Griffin Jones announced Nov. 20. Thirty-four counts of the federal indictment charge Houston physician Stanislaw Burzynski, MD, with mail fraud, while 40 counts cite him for introducing an unapproved drug into interstate commerce.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: